Loading clinical trials...
Loading clinical trials...
This trial will evaluate the combination of modified infusional 5-fluorouracil/ leucovorin, oxaliplatin (FOLFOX6), bevacizumab, and cetuximab in patients with metastatic colorectal cancer. FOLFOX6 has...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
NCT04450758 · Colon Cancer
NCT06746012 · Stage I Colon Cancer AJCC v8, Stage I Rectal Cancer AJCC v8, and more
NCT07494201 · Colorectal Cancer, Colon Cancer, and more
NCT05283330 · Cervical Cancer, Breast Cancer, and more
NCT04704661 · Advanced Breast Carcinoma, Advanced Colon Carcinoma, and more
Oncology Hematology Associates of SW Indiana
Evansville, Indiana
Consultants in Blood Disorders and Cancer
Louisville, Kentucky
Mercy Hospital
Portland, Maine
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions